Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: Clues towards a rational vaccination strategy

AIDS

Volumn 24, Issue 14, 2010, Pages 2287-2289

  Fritz, Stefanie ^a   Mossdorf, Erik ^b   Durovic, Bojana ^a   Zenhaeusern, Gabriela ^a   Conen, Anna ^b   Steffen, Ingrid ^d   Battegay, Manuel ^b   Nüesch, Reto ^b   Hess, Christoph ^a,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Hospital Epidemiology   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; VIROSOME VACCINE;

ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; INFLUENZA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 77956226029     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833c6f92     Document Type: Article

References (12)

1. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-135.
2. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993; 11:331-360.
3. Vieira P, Rajewsky K. Persistence of memory B cells in mice deprived of T cell help. Int Immunol 1990; 2:487-494.
4. Hebeis BJ, Klenovsek K, Rohwer P, Ritter U, Schneider A, Mach M, Winkler TH. Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004; 199:593-602.
5. Margolick JB, Munoz A, Donnenberg AD, Park LP, Galai N, Giorgi JV, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection: the Multicenter AIDS Cohort Study. Nat Med 1995; 1:674-680.
6. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-40.
7. Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, Wilschut J. The virosome concept for influenza vaccines. Vaccine 2005; 23 (Suppl 1):S26-S38.
8. Gasser O, Bihl FK, Wolbers M, Loggi E, Steffen I, Hirsch HH, et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4R T cell function irrespective of absolute CD4R T cell counts. PLoS Med 2007; 4:e96.
9. Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol 2006; 117:855-864.
10. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-245.
11. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205:1797-1805.
12. Bansal S, Pourbohloul B, Grenfell B, Meyers LA. The shifting demographic landscape of influenza. PLoS Curr Influenza 2009: RRN1047.